CMA pauses pharma probes to focus on covid-19
The UK’s Competition and Markets Authority has “paused” two probes into suspected collusion in the pharmaceutical sector as it reallocates resources to deal with the coronavirus pandemic.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.